
Tuberculosis Diagnostics Market by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test), Type (Point-of-Care Technologies, Rapid Test), End_User - Global Forecast 2024-2030
Description
Tuberculosis Diagnostics Market by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test), Type (Point-of-Care Technologies, Rapid Test), End_User - Global Forecast 2024-2030
The Tuberculosis Diagnostics Market size was estimated at USD 3.01 billion in 2023 and expected to reach USD 3.17 billion in 2024, at a CAGR 5.48% to reach USD 4.38 billion by 2030.
Global Tuberculosis Diagnostics Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Tuberculosis Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tuberculosis Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Tuberculosis Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Becton, Dickinson, and Company, bioMerieux SA, Bruker Corporation, Cepheid, Elisabeth Pharmacon, spol. s r.o., ELITech Group, F. Hoffmann-La Roche AG, Hologic Corporation, OSANG HEALTHCARE CO., LTD, PerkinElmer, Inc., Siemens AG, Thermo Fisher Scientific, Inc., and Türklab A.Ş..
Market Segmentation & Coverage
This research report categorizes the Tuberculosis Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Test Type
Drug-susceptibility Testing
Laboratory Methods
Mantoux Test
Nucleic Acid Testing
Radiographic Methods
Type
Point-of-Care Technologies
Rapid Test
End_User
Diagnostics Research Laboratory
Hospital & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Tuberculosis Diagnostics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tuberculosis Diagnostics Market?
3. What are the technology trends and regulatory frameworks in the Tuberculosis Diagnostics Market?
4. What is the market share of the leading vendors in the Tuberculosis Diagnostics Market?
5. Which modes and strategic moves are suitable for entering the Tuberculosis Diagnostics Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Tuberculosis Diagnostics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing burden of tuberculosis globally and need to diagnose at very early stage
- 5.1.1.2. Increasing R&D investments and intensive diagnostics products in pipelines
- 5.1.1.3. Supportive government initiatives and rising awareness in the emerging markets
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with tuberculosis diagnostics
- 5.1.2.2. Limited reimbursement options
- 5.1.3. Opportunities
- 5.1.3.1. Rising number of government awareness programs
- 5.1.3.2. Advancement in the diagnostics procedures
- 5.1.4. Challenges
- 5.1.4.1. Low coverage or absence of insurance in emerging markets
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Tuberculosis Diagnostics Market, by Test Type
- 6.1. Introduction
- 6.2. Drug-susceptibility Testing
- 6.3. Laboratory Methods
- 6.4. Mantoux Test
- 6.5. Nucleic Acid Testing
- 6.6. Radiographic Methods
- 7. Tuberculosis Diagnostics Market, by Type
- 7.1. Introduction
- 7.2. Point-of-Care Technologies
- 7.3. Rapid Test
- 8. Tuberculosis Diagnostics Market, by End_User
- 8.1. Introduction
- 8.2. Diagnostics Research Laboratory
- 8.3. Hospital & Clinics
- 9. Americas Tuberculosis Diagnostics Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Tuberculosis Diagnostics Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Tuberculosis Diagnostics Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. ACON Laboratories, Inc.
- 13.1.3. Becton, Dickinson, and Company
- 13.1.4. bioMerieux SA
- 13.1.5. Bruker Corporation
- 13.1.6. Cepheid
- 13.1.7. Elisabeth Pharmacon, spol. s r.o.
- 13.1.8. ELITech Group
- 13.1.9. F. Hoffmann-La Roche AG
- 13.1.10. Hologic Corporation
- 13.1.11. OSANG HEALTHCARE CO., LTD
- 13.1.12. PerkinElmer, Inc.
- 13.1.13. Siemens AG
- 13.1.14. Thermo Fisher Scientific, Inc.
- 13.1.15. Türklab A.Ş.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. TUBERCULOSIS DIAGNOSTICS MARKET RESEARCH PROCESS
- FIGURE 2. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TUBERCULOSIS DIAGNOSTICS MARKET DYNAMICS
- FIGURE 7. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
- FIGURE 8. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 10. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2023 VS 2030 (%)
- FIGURE 12. TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY END_USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. TUBERCULOSIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. TUBERCULOSIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.